EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pediatric Bone Marrow Failure: A Broad Landscape in Need of Personalized Management

Lotte T W Vissers, Mirjam van der Burg iD, Arjan C Lankester, Frans J W Smiers, Marije Bartels iD, Alexander B Mohseny

Journal of Clinical Medicine · 20.11.2023 · 12 (22) · 7185

DOI: 10.3390/jcm12227185 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 20.11.2023. Verfasst von Lotte T W Vissers und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Pediatric Immunology, Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, 2333 ZA Leiden…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 217 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Irreversible severe bone marrow failure (BMF) is a life-threatening condition in pediatric patients. Most important causes are inherited bone marrow failure syndromes (IBMFSs) and (pre)malignant diseases, such as myelodysplastic syndrome (MDS) and (idiopathic) aplastic anemia (AA). Timely treatment is essential to prevent infections and bleeding complications and increase overall survival (OS). Allogeneic hematopoietic stem cell transplantation (HSCT) provides a cure for most types of BMF but cannot restore non-hematological defects. When using a matched sibling donor (MSD) or a matched unrelated donor (MUD), the OS after HSCT ranges between 60 and 90%. Due to the introduction of post-transplantation cyclophosphamide (PT-Cy) to prevent graft versus host disease (GVHD), alternative donor HSCT can reach similar survival rates. Although HSCT can restore ineffective hematopoiesis, it is not always used as a first-line therapy due to the severe risks associated with HSCT. Therefore, depending on the underlying cause, other treatment options might be preferred. Finally, for IBMFSs with an identified genetic etiology, gene therapy might provide a novel treatment strategy as it could bypass certain limitations of HSCT. However, gene therapy for most IBMFSs is still in its infancy. This review summarizes current clinical practices for pediatric BMF, including HSCT as well as other disease-specific treatment options.

Schlagwörter

Stichwörter der Autor:innen

aplastic anemiabone marrow failurecytopeniagene therapyhematopoietic stem cell transplantationimmunosuppressive therapymyelodysplastic syndrome

Autor:innen und Institutionen

  • Laboratory for Pediatric Immunology, Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Department of Pediatrics, Hematology and Stem Cell Transplantation, Willem-Alexander Children's Hospital, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Department of Pediatric Hematology, Wilhelmina Children's Hospital, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.

ORCID-Profile: Mirjam van der Burg, Marije Bartels

Zitieren

APA

Vissers, L. T. W., van der Burg, M., Lankester, A. C., Smiers, F. J. W., Bartels, M., & Mohseny, A. B. (2023). Pediatric Bone Marrow Failure: A Broad Landscape in Need of Personalized Management. Journal of Clinical Medicine, 12(22), 7185. https://doi.org/10.3390/jcm12227185

Vancouver

Vissers LTW, van der Burg M, Lankester AC, Smiers FJW, Bartels M, Mohseny AB. Pediatric Bone Marrow Failure: A Broad Landscape in Need of Personalized Management. Journal of Clinical Medicine. 2023;12(22):7185. doi:10.3390/jcm12227185

BibTeX
@article{Vissers2023,
  author = {Vissers, Lotte T W and van der Burg, Mirjam and Lankester, Arjan C and Smiers, Frans J W and Bartels, Marije and Mohseny, Alexander B},
  title = {Pediatric Bone Marrow Failure: A Broad Landscape in Need of Personalized Management},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {22},
  pages = {7185},
  doi = {10.3390/jcm12227185}
}
Kostenlos starten →